Pharma stock play


PETALING JAYA: Rubber glove makers have taken a step back from their dominance of the stock exchange to pave way for pharmaceutical companies, following a shift in interest among investors.

Two research trials in China and the United Kingdom which yielded positive results drove investors into a frenzy to enter pharmaceutical-related companies, not only on Bursa Malaysia but also in key markets globally.

Get 30% off with our ads free Premium Plan!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Business News

Gaming stocks on track for recovery in 2025
iCents Group Holdings eyes listing on ACE Market
Infrastructure growth to support telecoms players
India regulators puncture a 10,000% stock rally
Amicorp denies 1MDB’s asset recovery claim
MMAG buys aircraft for RM21mil
Infrastructure and DC projects set to boost construction
Dividend galore for PNB’s unit trust holders
Beijing agrees to issue US$411bil treasury bond
Pan Merchant eyes ACE Market listing

Others Also Read